Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anetosacin vs levofloxacin for community-acquired pneumonia
CTR20160240Phase 2Active
- Sponsor
- Anhui Global Pharmaceutical Co., Ltd.
- Start
- May 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of anetosacin in community-acquired pneumonia (CAP), sponsored by Anhui Global Pharmaceutical Co., Ltd.. Started May 2016; status: active.
02
Drugs
anetosacin
03
Conditions
community-acquired pneumonia (CAP)
Beyond the preview
Go deeper on CTR20160240.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20160240.